UW Health and University of Wisconsin School of Medicine and Public Health have been selected as one of the first clinical sites in the country to study whether an investigational vaccine developed by the pharmaceutical company AstraZeneca can prevent COVID-19, the disease caused by the new coronavirus SARS-CoV-2.
University Communications